As a the world continues to battle this virus, much hope is focused on a “silver bullet” vaccine. But as nations rush to deliver protection, questions continue to arise on efficacy, safety, and deployment. The anxiety over these decisions, for some, rivals the anxiety over the virus itself. The more information released, the more we are being asked to absorb, and the more the confusion grows!
| less than a minute read
The Challenge on Which Vaccine and When to Vaccinate
On the same day that Pfizer and BioNTech released blockbuster results from the Phase III trial of their COVID-19 vaccine, Brazil threw a wrench into the plans of one of China’s most promising coronavirus vaccine candidates.
Characterized by the White House as “the most significant executive action any President has ever taken to protect Americans’ data...